DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ArQule, Inc. (ARQL)
« Back to company indexARQL Chatter Timeline
Stock Ticker for ARQL
Most Active Tweeters for ARQL
| User | Tweets |
|---|---|
| @biotechw2019 | 4 |
| @Gambiste1 | 4 |
| @AlertTrade | 2 |
| @AmericanBanking | 2 |
| @semodough | 2 |
Recent Tweets for ARQL
 |
@Altwhite4 $ARQL there’s about to be a breakout ? 2:09pm |
|
@Altwhite4 $ARQL back to 9$!!! 2:09pm |
 |
@HCWCO #HCWCO is initiating coverage on $ARQL, a development stage #biotech company that is developing four novel oral pro… https://t.co/9fVUZuZs2e 10:09am |
 |
@semodough derazantinib,consider them free call options. $ARQL launching 2 drugs in 2022 potentially 9:09am |
 |
@Gambiste1 RT @semodough: HCW $ARQL initiating coverage with a Buy rating and $13 price target.-Aiming for Success With Precision Drugs in Both Oncolo… 9:09am |
 |
@ProTradersNews $ARQL $ACB: Stifel cuts view on Aurora Cannabis to Sell in premarket analyst action: https://t.co/W4xQiCMAk7 8:09am |
|
@semodough HCW $ARQL initiating coverage with a Buy rating and $13 price target.-Aiming for Success With Precision Drugs in Bo… https://t.co/j2vck9OylU 8:09am |
 |
@AlertTrade RT @Briefingcom: $ARQL: H.C. Wainwright starts at Buy 7:09am |
 |
@AmericanBanking ArQule $ARQL Coverage Initiated at HC Wainwright https://t.co/DyU9eomHds #stocks 7:09am |
|
@AlertTrade UP/DOWNGRADES ? $ARQL: H.C. Wainwright starts at Buy https://t.co/6UXEtdHshk via ? https://t.co/VS8RO1bzXJ 7:09am |
 |
@Briefingcom $ARQL: H.C. Wainwright starts at Buy 7:09am |
 |
@biotechw2019 $ARQL monthly look: https://t.co/FCS3AGwvrQ September 14th 2019, 5:09pm |
|
@biotechw2019 $ARQL lower high and higher low and watch for the swing to 100 DMA rejection https://t.co/dEbJP2s3T0 September 13th 2019, 9:09am |
 |
@InsiderAlertsIA $ARQL: New Insider Filing on Chief Executive Officer PAOLO PUCCI: https://t.co/nNmpBHiSh6 September 12th 2019, 12:09pm |
 |
@confcalltran ArQule's Chief Executive Officer just picked up 5,000 shares https://t.co/GqjDZrfy05 $ARQL September 12th 2019, 10:09am |
 |
@subset_member wow, another nailbiter. $ARQL choked in the 4th quarter yesterday, but today it was $STML that couldn't complete t… https://t.co/zdvAAGnC44 September 11th 2019, 6:09pm |
|
@biotechw2019 $ARQL watch for today's close with a morning star 3 candles pattern to form ? https://t.co/bGpFqhTcTk September 11th 2019, 10:09am |
 |
@TickerReport Traders Purchase High Volume of Call Options on ArQule $ARQL https://t.co/NwaEzyPEvn September 11th 2019, 1:09am |
|
@AmericanBanking ArQule Sees Unusually Large Options Volume $ARQL https://t.co/NJ88cLHUdD #stocks September 10th 2019, 7:09am |
 |
@bbnsnews ArQule $ARQL Trading Down 13.1% https://t.co/A7JeRcCMJd September 10th 2019, 12:09am |
 |
@ThisLincolnian ArQule $ARQL Trading Down 13.1% https://t.co/ySpP2FAb1x September 10th 2019, 12:09am |
 |
@MC_OptionTrades $ARQL 17-Jan-20 ATM Implied Vol Jumps +15.3%. Straddle Implies a Move of ±49.9% https://t.co/oX4yVxMtRA September 9th 2019, 10:09pm |
 |
@jfais20 @lblegend33 Ridiculous IMO- re competitive positioning in BTK, $ARQL mgmt states that they chose not to go forward… https://t.co/g1hBNYJhHG September 9th 2019, 6:09pm |
 |
@BBSuns @GantosJ hey Joe-looks like $arql retraced to its trend support. U seeing any concerns in the chart? September 9th 2019, 4:09pm |
|
@biotechw2019 $ARQL Top of the gap support. Gap filling at $6.50 https://t.co/0f3OY0yUhH September 9th 2019, 3:09pm |
 |
@lblegend33 @GantosJ Here comes that gap fill in high 7s. Unbelievable what shorts can do to these bios. $arql September 9th 2019, 3:09pm |
|
@Gambiste1 RT @IlliniJJ: back in $ARQL and I am already in the red so I have that going for me.....wow downdrafting... September 9th 2019, 2:09pm |
|
@Gambiste1 RT @lblegend33: Oh $arql down 7% bc data coming from loxo $lly later this year? Makes perfect sense. That in a nut shell is the biotech sec… September 9th 2019, 2:09pm |
|
@Gambiste1 RT @Ogut_Ozgur: $arql management risk now coming into focus… https://t.co/I3QsfB6nHI September 9th 2019, 2:09pm |
 |
@IlliniJJ back in $ARQL and I am already in the red so I have that going for me.....wow downdrafting... September 9th 2019, 1:09pm |
 |
@Ogut_Ozgur $arql management risk now coming into focus… https://t.co/I3QsfB6nHI September 9th 2019, 1:09pm |
|
@Gambiste1 RT @semodough: $ARQL remaining catalysts Updated Phase I ARQ 531 data at American Society of Hematology (ASH) 2019 (12/07-12/10); (2) ARQ 7… August 11th 2019, 11:08pm |
 |
@ConsumerFeed Analysts Set ArQule, Inc. $ARQL PT at $12.20 https://t.co/to8cyFhZVM August 11th 2019, 9:08pm |
|
@semodough $ARQL remaining catalysts Updated Phase I ARQ 531 data at American Society of Hematology (ASH) 2019 (12/07-12/10);… https://t.co/VtQwC3hldW August 11th 2019, 9:08pm |
|
@TickerReport ArQule $ARQL Lowered to Hold at BidaskClub https://t.co/15SLo6H2YQ August 11th 2019, 5:08am |
 |
@1MinuteStock Wondering about risks of $ARQL? The 21-day volatility is 13.75% https://t.co/PPQMq1kdxv August 11th 2019, 3:08am |
|
@1MinuteStock Explore #fundamental numbers and pros and cons for $ARQL https://t.co/Ht11Qtyob5 August 11th 2019, 3:08am |
|
@1MinuteStock Wondering about #sentiment indicator for $ARQL? The Short Ratio is 2.63% https://t.co/QTDv7xRmdY August 11th 2019, 3:08am |
|
@AmericanBanking ArQule $ARQL Announces Quarterly Earnings Results https://t.co/yROhB6yhhd #stocks August 11th 2019, 1:08am |
|
@ConsumerFeed ArQule $ARQL Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS https://t.co/quEHiR8SxD August 11th 2019, 1:08am |
 |
@MarketChmln $ARQL upcoming event August 12: BTIG Biotechnology Conference. Options expiring on August 16 that cover the event h… https://t.co/78hKejxO7q August 11th 2019, 12:08am |
 |
@ZolmaxNews ArQule $ARQL Shares Gap Down to $8.86 https://t.co/kOG9Ze70Mj August 10th 2019, 7:08pm |
 |
@dailypoliticaln ArQule $ARQL Shares Gap Down to $8.86 https://t.co/4xdDWeuUkb August 10th 2019, 7:08pm |
|
@ConsumerFeed ArQule $ARQL Updates FY 2019 Earnings Guidance https://t.co/25SHAtisNY August 10th 2019, 5:08pm |
|
@ZolmaxNews ArQule $ARQL Updates FY 2019 Earnings Guidance https://t.co/WVoNZvKFH4 August 10th 2019, 5:08pm |
 |
@macondailynews ArQule $ARQL Updates FY 2019 Earnings Guidance https://t.co/ag7asMpdtb August 10th 2019, 2:08pm |
 |
@dispatchtribune ArQule $ARQL Updates FY 2019 Earnings Guidance https://t.co/ISuVJQpe41 August 10th 2019, 1:08pm |
 |
@dakotafinancial ArQule $ARQL Stock Rating Lowered by BidaskClub https://t.co/szZqnjvSLu August 10th 2019, 10:08am |
|
@macondailynews Zacks: Analysts Anticipate ArQule, Inc. $ARQL Will Post Earnings of -$0.10 Per Share https://t.co/OoYsghgO8F August 9th 2019, 10:08pm |
|
@dakotafinancial ArQule, Inc. $ARQL Receives $12.20 Average Price Target from Brokerages https://t.co/1xnqFKDG3s August 9th 2019, 7:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.